PMID- 29032661 OWN - NLM STAT- MEDLINE DCOM- 20180928 LR - 20220311 IS - 2005-1212 (Electronic) IS - 1976-2283 (Print) IS - 1976-2283 (Linking) VI - 12 IP - 1 DP - 2018 Jan 15 TI - A Prospective Study of Eosinophilic Esophagitis and the Expression of Tight Junction Proteins in Patients with Gastroesophageal Reflux Disease Symptoms. PG - 30-37 LID - 10.5009/gnl16600 [doi] AB - BACKGROUND/AIMS: Eosinophilic esophagitis (EoE) is often erroneously diagnosed as gastroesophageal reflux disease (GERD). The aim of this study is to investigate the prevalence of EoE and the expression of tight junction (TJ) proteins in patients with GERD symptoms. METHODS: One hundred patients with GERD symptoms and 10 healthy controls were prospectively studied. Sixty-two patients had symptoms refractory to proton pump inhibitors (PPI). All patients underwent esophageal biopsy. Patients were diagnosed with EoE if the number of eosinophil granulocytes per high-power field was >/=15. Immunohistochemical analysis of TJ proteins (claudin-1, claudin-4, occludin, and zonula occludin-1 [ZO-1]) was performed. RESULTS: EoE was diagnosed in six of 100 patients (6%) with GERD symptoms and in six patients (9.7%) of 62 patients with PPI-refractory GERD. Only one had typical EoE endoscopic findings. The proportion of ZO-1-positive cells was significantly lower in the lower than in the middle esophagus (56.0%+/-14.0% vs 66.0%+/-11.5%, p<0.05). There were no significant correlations between TJ protein expression and GERD symptoms. CONCLUSIONS: The prevalence of EoE among patients with PPI-refractory GERD is approximately 10%. Regardless of endoscopic findings, esophageal biopsy is crucial in diagnosing EoE. The disruption of ZO-1 expression in the lower esophagus is significantly associated with GERD symptoms. FAU - Okimoto, Kenichiro AU - Okimoto K AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Arai, Makoto AU - Arai M AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Ishigami, Hideaki AU - Ishigami H AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Saito, Keiko AU - Saito K AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Minemura, Shoko AU - Minemura S AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Maruoka, Daisuke AU - Maruoka D AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Matsumura, Tomoaki AU - Matsumura T AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Nakagawa, Tomoo AU - Nakagawa T AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Katsuno, Tatsuro AU - Katsuno T AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Suzuki, Masaki AU - Suzuki M AD - Department of Diagnostic Pathology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Nakatani, Yukio AU - Nakatani Y AD - Department of Diagnostic Pathology, Chiba University Graduate School of Medicine, Chiba, Japan. FAU - Yokosuka, Osamu AU - Yokosuka O AD - Department of Gastroenterology, Chiba University Graduate School of Medicine, Chiba, Japan. LA - eng PT - Journal Article PL - Korea (South) TA - Gut Liver JT - Gut and liver JID - 101316452 RN - 0 (Biomarkers) RN - 0 (Tight Junction Proteins) SB - IM MH - Aged MH - Biomarkers/metabolism MH - Biopsy MH - Case-Control Studies MH - Diagnosis, Differential MH - Eosinophilic Esophagitis/diagnosis/*epidemiology/*metabolism MH - Esophagus/metabolism MH - Female MH - Gastroesophageal Reflux/*complications MH - Humans MH - Male MH - Middle Aged MH - Prevalence MH - Prospective Studies MH - Tight Junction Proteins/*metabolism PMC - PMC5753681 OTO - NOTNLM OT - Eosinophilic esophagitis OT - Gastroesophageal reflux OT - Proton pump inhibitor OT - Tight junctions OT - Zonula occludin-1 COIS- CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. EDAT- 2017/10/17 06:00 MHDA- 2018/10/03 06:00 PMCR- 2018/01/01 CRDT- 2017/10/17 06:00 PHST- 2016/12/14 00:00 [received] PHST- 2017/02/19 00:00 [revised] PHST- 2017/03/27 00:00 [accepted] PHST- 2017/10/17 06:00 [pubmed] PHST- 2018/10/03 06:00 [medline] PHST- 2017/10/17 06:00 [entrez] PHST- 2018/01/01 00:00 [pmc-release] AID - gnl16600 [pii] AID - gnl-12-030 [pii] AID - 10.5009/gnl16600 [doi] PST - ppublish SO - Gut Liver. 2018 Jan 15;12(1):30-37. doi: 10.5009/gnl16600.